The effect of DMD gene expression on glioma survival was specific to only WHO grade II LGG; high-grade (grade III) anaplastic tumours and high-grade (grade IV) glioblastoma TCGA datasets did not result in any significant survival differences when stratified by high/low DMD expression (Supplementary Fig. S1). The gene discussed is DMD; the disease is central nervous system cancer.